Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

Status Not yet recruiting

Clinical Trial Summary

Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy

Clinical Trial Description

Brinzolamide is a carbonic anhydrase inhibitor. Previously, carbonic anhydrase inhibitors have been shown to be effective for the treatment of macular edema when administered orally, also for central serous chorioretinopathy. However, this treatment carries the risk of severe side effects.

The goal of this study is to examine the efficacy of the topical form of treatment of carbonic anhydrase inhibitors in patients with chronic, non-resolving, central serous chorioretinopathy. ;

Study Design

Related Conditions & MeSH terms

Central Serous Chorioretinopathy

Clinical Trial Details

NCT number	NCT03542006
Study type	Interventional
Source	Tel-Aviv Sourasky Medical Center
Contact	Dinah Zur, MD
Phone	+97236973408
Email	dinahzur@gmail.com
Status	Not yet recruiting
Phase	Phase 2
Start date	June 1, 2018
Completion date	April 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03497000` - Effects of OCTA-guided PDT in Acute CSC	N/A
Recruiting	`NCT03692169` - The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC
Not yet recruiting	`NCT02215330` - A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy	Phase 2/Phase 3
Completed	`NCT01971190` - Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy	Phase 2
Completed	`NCT01990677` - Eplerenone for the Treatment of Central Serous Chorioretinopathy	N/A
Active, not recruiting	`NCT01710332` - The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy	Phase 2
Active, not recruiting	`NCT00403884` - Selective RPE Laser Treatment (SRT) for Various Macular Diseases	N/A
Recruiting	`NCT05570591` - Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy	N/A
Recruiting	`NCT05589974` - Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Completed	`NCT05104138` - Eplerenone Versus PDT: Comparative Study by OCTA
Terminated	`NCT01982383` - Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy	N/A
Completed	`NCT01880788` - Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD	N/A
Completed	`NCT01327170` - Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy	N/A
Completed	`NCT01019668` - Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy	N/A
Recruiting	`NCT06346405` - Central Serous Chorioretinopathy and Micropulse Laser Treatment
Recruiting	`NCT02141308` - OCT in Rare Chorioretinal Diseases
Completed	`NCT01822561` - Eplerenone for Central Serous Chorioretinopathy	Phase 2
Completed	`NCT00802906` - Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)	N/A
Withdrawn	`NCT05679180` - Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE	N/A
Completed	`NCT05686421` - Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations	N/A